Company / R&D per Share
Olema Pharmaceuticals, Inc. R&D per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.12
FY2024
5-year range
$1.29 / $2.12
FY2020-FY2024
Trend
+11.3%
vs FY2023
Sector context
#97 of 208
Health Care
What the data says
At $2.12, Olema Pharmaceuticals, Inc.'s r&d per share ranks #97 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 6 years, ranging from $1.29 in FY2021 to $2.12 in FY2024.
Based on SEC 10-K filings.
2.12 in FY2024 with a 5-year CAGR of +7.0%.
Improved from $2.06 to $2.12 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
#97 of 208 in Health CareTop 47% of 208This company $2.12 Sector average $28.82
▼
-92.6% below sector average
Key checks
Key Insights
- In FY2024, r&d per share increased 11.3% year-over-year.
- Ranks #97 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.12 | +11.3% |
| FY2023 | $1.90 | -7.5% |
| FY2022 | $2.06 | +59.1% |
| FY2021 | $1.29 | -33.8% |
| FY2020 | $1.95 | +29.1% |
| FY2019 | $1.51 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026